Mov Disord Vol 35, Suppl 1 Archives - Page 124 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Say “AH~”: Vocal Analysis in Parkinson’s Disease and Essential Tremor
J.E Park, S.W Oh, J.Y Shin, S.Y Lee, S.H Hong, N.H Ahn, H.J Kim, K.H Lee, J.E Bae, H.B Lee (Goyang, Republic of Korea)
Objective: We aimed to investigate useful vocal parameters in differentiating PD and ET, using a machine-learning algorithm. Background: Correlation between Parkinson's disease (PD) and essential tremor (ET)…
MDS Virtual Congress 2020
The Future of Hospitalization for People with Parkinson’s Disease
A. Wallis, D. Perret (Miami, FL, USA)
Objective: To share the discussion of the December 6, 2019 Parkinson’s Hospitalization Convening. Background: On December 6, 2019, The Parkinson’s Foundation (PF) assembled thought leaders…
MDS Virtual Congress 2020
Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology
E. Howard, D. Irwin, K. Rascovsky, N. Nevler, S. Shellikeri, D. Mechanic-Hamilton, T. Tropea, A. Chen-Plotkin, A. Siderowf, D. Weintraub, L. Shaw, J. Trojanowski, M. Grossman, K. Cousins (Philadelphia, PA, USA)
Objective: To test the association between confrontation naming performance and Alzheimer’s disease (AD) co-pathology as defined by cerebrospinal fluid (CSF) biomarkers in Lewy body dementia…
MDS Virtual Congress 2020
Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease
P. Bugalho, F. Ladeira, R. Barbosa, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisboa, Portugal)
Objective: Assess the predicitive value of dream content for cognitive dysfuncion progression in Parkinson's Disease (PD). Background: PD patients frequently complain of vivid dreams. Cross-sectional…
MDS Virtual Congress 2020
Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials
P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)
Objective: This study aimed to evaluate the effects of rTMS for improving cognition of PD patients. Background: Up to 20%–50% of patients with Parkinson’s disease…
MDS Virtual Congress 2020
Task based profiles of language impairment in Parkinson’s Disease
A. Lowit, M. Roheger, E. Kalbe, T. Thies, J. Steffen, M. Barbe (Glasgow, United Kingdom)
Objective: This study aimed to add to our understanding of language impairment in people with Parkinson's Disease (PwPD). Background: Language difficulties are increasingly reported in…
MDS Virtual Congress 2020
Improved verb use in Parkinson’s disease following intensive voice treatment
A. Ramage, C. Fox, A. Halpern, L. Ramig (Durham, NH, USA)
Objective: To identify changes in language production secondary to voice treatment in speakers with Parkinson’s disease (PD). Background: Given the role of voice in language…
MDS Virtual Congress 2020
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus
Q. Wang (Guangzhou, China)
Objective: Identifying the risk factors of dementia in patients with both Parkinson’s disease (PD) and type 2 diabetes mellitus (DM) (PD-DM) is clinically relevant and…
MDS Virtual Congress 2020
The ADNPC-RS: a risk score that identifies Lewy body disease individuals at risk for developing concomitant Alzheimer’s pathology
D. Dai, T. Tropea, J. Robinson, E. Suh, H. Hurtig, D. Weintraub, V. Van Deerlin, E. Lee, J. Trojanowski, A. Chen-Plotkin (Philadelphia, PA, USA)
Objective: To identify which common genetic variants that confer risk for Alzheimer’s disease (AD) also predict the development of concomitant AD pathology in patients with…
MDS Virtual Congress 2020
Survival in Parkinson’s Disease and Association with MAPT and APOE
S. Kola, S. Armasu, D. Weis, O. Ross, D. Maraganore, A. Hassan (Rochester, MN, USA)
Objective: To assess survival in a large cohort of Parkinson's disease (PD) patients, and to determine if survival correlates with MAPT and APOE gene variants.…